A novel human papillomavirus and host DNA methylation score and detection of cervical adenocarcinoma

被引:5
|
作者
Gradissimo, Ana [1 ,2 ]
Clarke, Megan A. [3 ]
Xue, Xiaonan [4 ]
Castle, Philip E. [3 ,4 ]
Raine-Bennett, Tina R. [5 ]
Schiffman, Mark [3 ]
Wentzensen, Nicolas [3 ]
Strickler, Howard D. [4 ,8 ]
Burk, Robert D. [1 ,4 ,6 ,7 ]
机构
[1] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10514 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY USA
[3] NCI, Div Canc Epidemiol & Genet, Bethesda, MD USA
[4] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY USA
[5] Kaiser Permanente Div Res, Oakland, CA USA
[6] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY USA
[7] Albert Einstein Coll Med, Dept Gynecol & Womens Hlth, Bronx, NY USA
[8] Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2023年 / 115卷 / 12期
基金
美国国家卫生研究院;
关键词
UNITED-STATES; CANCER; HAPLOTYPES; PRECANCER; TRENDS; WOMEN;
D O I
10.1093/jnci/djad134
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The widespread introduction of Pap testing in the 1960s was followed by substantial reductions in the incidence of cervical squamous cell cancer (SCC). However, the incidence of cervical adenocarcinoma (ADC) did not decrease, likely because of low Pap test sensitivity for ADC and adenocarcinoma in situ (AIS). This study assessed a novel human papillomavirus (HPV) and host DNA Methylation Score for AIS and ADC screening.Methods We measured methylation levels at CpG sites in the L2/L1 open reading frames of HPV16, HPV18, and HPV45-as well as 2 human loci, DCC and HS3ST2. Specifically, we tested exfoliated cervicovaginal cells from women in the HPV Persistence and Progression (PaP) cohort who were positive for 1 of HPV16, 18, or 45, including: 1) 176 with AIS/ADC, 2) 353 with cervical intraepithelial neoplasia-3 (CIN3) or SCC, and 3) controls who either cleared (HPV-Clearers; n = 579) or had persistent HPV16, 18, or 45 infection (HPV-Persisters; n = 292). CpG site-specific methylation percentages were measured using our reported next-generation methods. The Methylation Score was the average methylation percentage across all 35 CpG sites tested.Results Each individual CpG site had higher methylation percentages in exfoliated cervicovaginal cells collected from patients with AIS/ADC, and as well as those with CIN3/SCC, relative to either control group (weakest P = .004). The Methylation Score for AIS/ADC had a sensitivity of 74% and specificity of 89%. The multivariate odds ratio (OR) between the Methylation Score (4th vs 1st quartile) for AIS/ADC was ORq4-q1 = 49.01 (PBenjamini-Hochberg = 4.64E-12), using HPV-Clearers as controls. CIN3/SCC had similar, albeit weaker, associations with the Methylation Score.Conclusions HPV16/18/45-infected women with Methylation Scores in the highest quartile had very high odds of AIS/ADC, suggesting they may warrant careful histologic evaluation of the cervical transition zone (eg, conization or loop electrosurgical excision procedure [LEEP]).
引用
收藏
页码:1535 / 1543
页数:9
相关论文
共 50 条
  • [1] Detection and Identification of Human Papillomavirus in Cervical Adenocarcinoma
    郭毅
    李威
    王倩
    李慧
    ChineseJournalofCancerResearch, 2008, (03) : 177 - 180
  • [2] Detection and identification of human papillomavirus in cervical adenocarcinoma
    Guo Yi
    Li Wei
    Wang Qian
    Li Hui
    CHINESE JOURNAL OF CANCER RESEARCH, 2008, 20 (03) : 177 - 180
  • [3] Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer
    Clarke, Megan A.
    Wentzensen, Nicolas
    Mirabello, Lisa
    Ghosh, Arpita
    Wacholder, Sholom
    Harari, Ariana
    Lorincz, Attila
    Schiffman, Mark
    Burk, Robert D.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (12) : 2125 - 2137
  • [4] Detection of human papillomavirus DNA types 16 and 18 in cervical adenocarcinoma and its precursors by PCR
    El-Mansi, M
    Williams, ARW
    Morris, RG
    BRITISH JOURNAL OF CANCER, 2004, 91 : S42 - S42
  • [5] Detection and genotyping of human papillomavirus in biopsies of uterine cervical adenocarcinoma
    Brebi M, Priscilla
    Gloria Ili G, Carmen
    Lopez M, Jaime
    Garcia M, Patricia
    Melo A, Angelica
    Montenegro H, Sonia
    Leal R, Pamela
    Guzman G, Pablo
    Carlos Roa S, Juan
    REVISTA MEDICA DE CHILE, 2009, 137 (03) : 377 - 382
  • [6] A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes
    Brentnall, Adam R.
    Vasiljevic, Natasa
    Scibior-Bentkowska, Dorota
    Cadman, Louise
    Austin, Janet
    Szarewski, Anne
    Cuzick, Jack
    Lorincz, Attila T.
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (06) : 1425 - 1432
  • [7] Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma
    Pirog, EC
    Kleter, B
    Olgac, S
    Bobkiewicz, P
    Lindeman, J
    Quint, WGV
    Richart, RM
    Isacson, C
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (04): : 1055 - 1062
  • [8] DETECTION OF HUMAN PAPILLOMAVIRUS DNA IN CERVICAL LESIONS BY INSITU DNA HYBRIDIZATION
    YUN, K
    MOLENAAR, AJ
    WILKINS, RJ
    PATHOLOGY, 1989, 21 (01) : 1 - 4
  • [9] Detection of human papillomavirus types in cervical adenocarcinoma by the polymerase chain reaction
    Lee, MF
    Chang, MC
    Wu, CH
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1998, 63 (03) : 265 - 270
  • [10] HUMAN PAPILLOMAVIRUS DETECTION IN CERVICAL ADENOCARCINOMA BY POLYMERASE CHAIN-REACTION
    MILDELANGOSCH, K
    SCHREIBER, C
    BECKER, G
    LONING, T
    STEGNER, HE
    HUMAN PATHOLOGY, 1993, 24 (06) : 590 - 594